Advancing Therapeutic Strategies for Inherited Retinal Degeneration: Recommendations From the Monaciano Symposium
Open Access
- 1 February 2015
- journal article
- review article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 56 (2) , 918-931
Abstract
Although rare in the general population, retinal dystrophies occupy a central position in current efforts to develop innovative therapies for blinding diseases. This status derives, in part, from the unique biology, accessibility, and function of the retina, as well as from the synergy between molecular discoveries and transformative advances in functional assessment and retinal imaging. The combination of these factors has fueled remarkable progress in the field, while at the same time creating complex challenges for organizing collective efforts aimed at advancing translational research. The present position paper outlines recent progress in gene therapy and cell therapy for this group of disorders, and presents a set of recommendations for addressing the challenges remaining for the coming decade. It is hoped that the formulation of these recommendations will stimulate discussions among researchers, funding agencies, industry, and policy makers that will accelerate the development of safe and effective treatments for retinal dystrophies and related diseases.Keywords
This publication has 127 references indexed in Scilit:
- AAV-Mediated Gene Therapy for Choroideremia: Preclinical Studies in Personalized ModelsPLOS ONE, 2013
- Targeting Photoreceptors via Intravitreal Delivery Using Novel, Capsid-Mutated AAV VectorsPLOS ONE, 2013
- Intravitreal delivery of AAV-NDI1 provides functional benefit in a murine model of Leber hereditary optic neuropathyEuropean Journal of Human Genetics, 2012
- Self-Formation of Optic Cups and Storable Stratified Neural Retina from Human ESCsCell Stem Cell, 2012
- Embryonic stem cell trials for macular degeneration: a preliminary reportThe Lancet, 2012
- Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 MutationsArchives of Ophthalmology (1950), 2012
- Optic Vesicle-like Structures Derived from Human Pluripotent Stem Cells Facilitate a Customized Approach to Retinal Disease TreatmentStem Cells, 2011
- Naturally occurring animal models with outer retina phenotypesVision Research, 2009
- Intravitreal delivery of AAV8 retinoschisin results in cell type-specific gene expression and retinal rescue in the Rs1-KO mouseGene Therapy, 2009
- Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapyGene Therapy, 2008